Amitoj S. Sawhney

Amitoj S. Sawhney

Auto-generated profile, based on publicly available information

Amitoj S. Sawhney

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ASAmitoj S. Sawhney
Amitoj S. Sawhney
BDBrian J. Deskin
Brian J. Deskin
JCJunming Cai
Junming Cai
DGDaniel Gibbard
Daniel Gibbard
GAGibran Ali
Gibran Ali
DBDouglas G. Brownfield
Douglas G. Brownfield
Alveolar Type 1 and Type 2 cells are vital for lung gas exchange and become compromised in several diseases. While key differentiation signals are known, their emergence and fate plasticity are unclear. Here we show in the embryonic lung that single AT2s emerge at intermediate zones, extrude, and connect with nearby epithelium via interlumenal junctioning. We observe AT2s retain fate plasticity until the bZIP transcription factor C/EBPα suppresses Notch signaling at a novel Dlk1 enhancer. Both Dlk1 and Cebpa are regulated by the polycomb repressive complex (PRC2), which together form a “pulse generator” circuit that times Dlk1 expression and thus Notch activation, resulting in a “salt and pepper” pattern of AT1 and AT2 fate. In injured adult lungs, C/EBPα downregulation is required to re-access AT2 fate plasticity and is mediated by the dominant negative C/EBP family member CHOP. Finally, Cebpa loss also activates a “defender” AT2 state, distinct from its reparative state, and we propose AT2s toggle between either state following infection to protect and repair alveoli.

13 November 2026 in Cardiovascular Research
Verified
Journal Article
Closed access
ASAmitoj S Sawhney
Amitoj S Sawhney
ANAyat Nayyer
Ayat Nayyer
Sean WuSean Wu
Sean Wu